Skip to main content

Table 2 Average prostate cancer detection tests in Victoria 2015–2019 and tests in 2020

From: The effect of COVID-19 on prostate cancer testing in Australia

 

Average 2015–2019 (95%CI)

2020

Difference (95%CI; and % of average)

Significance

PSA tests

181,056 (175,425 to 185,379)

167,426

− 13,629 (8671–18,588; 92)

P = 0.002 (t = 7.63)

Prostate MRI*

9826†

8683

− 1143 (‡; 88)

N/A‡

Prostate biopsies

5101 (4730–5906)

5201

 + 100 (− 472 to 672; 102)

P = 0.653 (t = − 0.49)

  1. *Data from DHS grouped for Victoria and Tasmania
  2. Full year data only available for 2019–2020
  3. Statistical analysis not possible owing to limited data set